Daniel P. Petrylak, MD | Authors

Daniel P. Petrylak, MD, Reviews Ongoing Clinical Trials in Bladder Cancer

April 22, 2022

At the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies, Daniel P. Petrylak, MD, spoke about ongoing trials may hold promise for the treatment of patients with bladder cancer.

Avelumab Maintenance for Urothelial Carcinoma: Real-World Evidence

December 22, 2021

Daniel Petrylak, MD and Donald Barry Boyd, MD, MS, examine real-world data presented in the recent publication, “Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice.”